Roxana E. Iacob
Impact in
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Immunology and Allergy top 5%
Papers in
-
- Protein purification and stability 4
- Protein Structure and Dynamics 3
-
- Monoclonal and Polyclonal Antibodies Research 10
- Co-authors
- John R. Engen (27 shared papers)Nathanael S. Gray (3 shared papers)Marzia Capelletti (1 shared paper)Cai‐Hong Yun (1 shared paper)Lucian R. Chirieac (1 shared paper)Liang Chen (1 shared paper)Dalia Ercan (1 shared paper)Wenjun Zhou (1 shared paper)
- Journals
- Journal of the American Society for Mass Spectrometry (5 papers)Journal of Biological Chemistry (3 papers)PLoS ONE (2 papers)Analytical Chemistry (2 papers)Nature (2 papers)
- Partner nations
- United StatesGermanyRomania
In The Last Decade
Roxana E. Iacob
34 papers receiving 2.5k citations
Roxana E. Iacob's Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 646
- Immunology and Allergy 136
- Spectroscopy 410
- Molecular Biology 1.6k
- Hematology 207
Countries citing papers authored by Roxana E. Iacob
This map shows the geographic impact of Roxana E. Iacob's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roxana E. Iacob with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roxana E. Iacob more than expected).
Fields of papers citing papers by Roxana E. Iacob
This network shows the impact of papers produced by Roxana E. Iacob. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roxana E. Iacob. The network helps show where Roxana E. Iacob may publish in the future.
Co-authors
The 25 scholars most cited alongside Roxana E. Iacob, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Novel mutant-selective EGFR kinase inhibitors against EGFR T790M Hit paper breakdown → | 2009 | 817 |
| 2 | 2017 | 218 | |
| 3 | 2013 | 164 | |
| 4 | 2017 | 146 | |
| 5 | 2014 | 126 | |
| 6 | 2013 | 99 | |
| 7 | 2012 | 89 | |
| 8 | 2013 | 79 | |
| 9 | 2023 | 64 | |
| 10 | 2009 | 64 | |
| 11 | 2008 | 62 | |
| 12 | 2011 | 57 | |
| 13 | 2007 | 55 | |
| 14 | 2012 | 49 | |
| 15 | 2007 | 38 | |
| 16 | 2014 | 35 | |
| 17 | 2014 | 33 | |
| 18 | 2018 | 30 | |
| 19 | 2013 | 30 | |
| 20 | 2018 | 29 |
About Roxana E. Iacob
Roxana E. Iacob is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Spectroscopy, Hematology and Rheumatology, having authored 34 papers that have together received 2.5k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (10 papers), Mass Spectrometry Techniques and Applications (8 papers), Chronic Myeloid Leukemia Treatments (5 papers), Protein purification and stability (4 papers), Analytical Chemistry and Chromatography (4 papers), Eosinophilic Disorders and Syndromes (4 papers), Quinazolinone synthesis and applications (3 papers) and Protein Structure and Dynamics (3 papers). The work is most often cited by research in Oncology (646 citations), Immunology and Allergy (136 citations), Spectroscopy (410 citations), Molecular Biology (1.6k citations) and Hematology (207 citations). Roxana E. Iacob has collaborated with scholars based in United States, Germany and Romania. Frequent co-authors include John R. Engen, Nathanael S. Gray, Marzia Capelletti, Cai‐Hong Yun, Lucian R. Chirieac, Liang Chen, Dalia Ercan, Wenjun Zhou, Pasi A. Jänne and Michael J. Eck. Their work appears in journals such as Journal of the American Society for Mass Spectrometry, Journal of Biological Chemistry, PLoS ONE, Analytical Chemistry and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.